Clinical Trials List
2025-01-01 - 2026-12-31
Phase II
Recruiting2
ICD-10G23.0
Hallervorden-Spatz disease
ICD-10G23.1
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
ICD-10G23.2
Striatonigral degeneration
ICD-10G23.8
Other specified degenerative diseases of basal ganglia
ICD-10G23.9
Degenerative disease of basal ganglia, unspecified
ICD-10G90.3
Multi-system degeneration of the autonomic nervous system
ICD-9333.0
Other degenerative diseases of the basal ganglia
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 夏昀 Division of Ophthalmology
- Ruey-Meei Wu Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
75 participants
